Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Pharma
Of biopharma's top 25 companies, 9 had double-digit sales bumps
Biopharma sales boomed in Q2. Of the top 25 revenue companies, nine had YoY double-digit increases and 13 saw sequential increases of at least 10%.
Kevin Dunleavy
Aug 12, 2026 11:47am
Takeda, Daiichi, Astellas and more—Fierce Pharma Asia
Aug 7, 2026 8:35am
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Jul 17, 2026 9:38am
FDA expands Padcev-Keytruda combo to more MIBC patients
Jul 10, 2026 1:10pm
Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia
Jun 26, 2026 8:51am
Astellas, Takeda, RA Capital—Fierce Pharma Asia
Jun 12, 2026 8:23am
